Review
Published on 23 Sep 2015
An animal model of differential genetic risk for methamphetamine intake
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00327
- 7,136 views
- 21 citations
Type at least 3 characters
1,001 articles
Articles
Original Research
Published on 23 Sep 2015
Enhanced functional connectivity involving the ventromedial hypothalamus following methamphetamine exposure
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00326
- 4,603 views
- 8 citations
Original Research
Published on 17 Sep 2015
Methylenedioxypyrovalerone (MDPV) mimics cocaine in its physiological and behavioral effects but induces distinct changes in NAc glucose
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00324
- 53,465 views
- 17 citations
Review
Published on 03 Sep 2015
Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00297
- 14,120 views
- 91 citations
Review
Published on 26 Aug 2015
Effects of anabolic-androgens on brain reward function
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00295
- 53,992 views
- 36 citations
Review
Published on 10 Aug 2015
A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)'s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00279
- 12,711 views
- 69 citations
Mini Review
Published on 29 Jul 2015
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00259
- 9,907 views
- 69 citations
Mini Review
Published on 21 Jul 2015
Antidepressant mechanism of ketamine: perspective from preclinical studies
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00249
- 23,712 views
- 51 citations
Review
Published on 03 Jul 2015
Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00229
- 24,314 views
- 148 citations
Review
Published on 03 Jul 2015
Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00225
- 168,236 views
- 127 citations
Review
Published on 18 Jun 2015
The role of maternal obesity in the risk of neuropsychiatric disorders
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00194
- 31,034 views
- 246 citations
Original Research
Published on 17 Jun 2015
Subchronic toxicity study of standardized methanolic extract of Mitragyna speciosa Korth in Sprague-Dawley Rats
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00189
- 9,846 views
- 35 citations
Review
Published on 16 Jun 2015
Amylin at the interface between metabolic and neurodegenerative disorders
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00216
- 17,264 views
- 80 citations
Review
Published on 16 Jun 2015
Aberrant insulin signaling in Alzheimer's disease: current knowledge
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00204
- 28,173 views
- 236 citations
Original Research
Published on 16 Jun 2015
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00218
- 13,433 views
- 105 citations
Mini Review
Published on 09 Jun 2015
Therapeutic potential of mGluR5 targeting in Alzheimer's disease
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2015.00215
- 14,383 views
- 72 citations